Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05424003
What this trial is testing

Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant

Who this might be right for
NAFLD
University of Virginia 50
Not applicableEnded earlyNCT05184283
What this trial is testing

Utilization of MAsS in Patients Undergoing LT for HCC

Who this might be right for
NAFLDHepatocellular CarcinomaLiver Diseases+3 more
Columbia University 11
Not applicableUnknownNCT03913351
What this trial is testing

Lifestyle Modification Programme for HIV-infected Individuals With Fatty Liver

Who this might be right for
NAFLDHiv
Chinese University of Hong Kong 96
Not applicableEnded earlyNCT02134522
What this trial is testing

The Role of Obstructive Sleep Apnea in Children With Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver Disease
Yale University 1
Not applicableStudy completedNCT06423846
What this trial is testing

Total Intravenous Anesthesia Versus Inhalation Anesthesia on Postoperative Liver Function

Who this might be right for
Laparoscopic Sleeve Gastrectomy
Benha University 80
Large-scale testing (Phase 3)Active Not RecruitingNCT05500222
What this trial is testing

Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

Who this might be right for
NASHCirrhosis, Liver
Madrigal Pharmaceuticals, Inc. 845
Not applicableLooking for participantsNCT06802731
What this trial is testing

LivQ-box® Parameters in the Diagnosis of Liver Inflammation

Who this might be right for
Liver InflammationFatty Liver Disease
Wuxi Hisky Medical Technology Co Ltd 365
Not applicableLooking for participantsNCT06751862
What this trial is testing

The Role of Sugars in Fat Accumulation in the Liver

Who this might be right for
Fatty Liver Disease
Institute for Clinical and Experimental Medicine 40
Not applicableEnded earlyNCT06123858
What this trial is testing

Non-alcoholic Steatohepatitis Registry Platform Study

Who this might be right for
NASH With Fibrosis
AstraZeneca 1,122
Early research (Phase 1)Study completedNCT00389376
What this trial is testing

Phase I Trial of Silymarin for Chronic Liver Diseases

Who this might be right for
Hepatitis CNon-Alcoholic Fatty Liver Disease
National Center for Complementary and Integrative Health (NCCIH) 56
Not applicableUnknownNCT06413069
What this trial is testing

Effects of Almonds in Glucose-intolerant Adults (AGAMEMNON)

Who this might be right for
PreDiabetesNAFLD
Charite University, Berlin, Germany 150
Large-scale testing (Phase 3)Looking for participantsNCT06318169
What this trial is testing

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc. 1,350
Not applicableNot Yet RecruitingNCT04925362
What this trial is testing

THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis)

Who this might be right for
NAFLDNASHNASH - Nonalcoholic Steatohepatitis+2 more
Assistance Publique - Hôpitaux de Paris 900
Not applicableLooking for participantsNCT07070362
What this trial is testing

Digital Early Warning System for Acute Lung Injury in Liver Surgery

Who this might be right for
Acute Lung Injury(ALI)Liver CirrhosisARDS, Human+4 more
Beijing Tsinghua Chang Gung Hospital 3,000
Testing effectiveness (Phase 2)Study completedNCT02686762
What this trial is testing

Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis

Who this might be right for
Non-alcoholic SteatohepatitisFibrosisLiver Diseases
Conatus Pharmaceuticals Inc. 318
Not applicableUnknownNCT02716870
What this trial is testing

Meta-analyses of the Effect of Important Food Sources of Sugars on Cardiometabolic Risk Factors

Who this might be right for
DyslipidemiaDiabetesPrediabetes+5 more
University of Toronto 1
Early research (Phase 1)Looking for participantsNCT06704516
What this trial is testing

COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study

Who this might be right for
MenopauseMetabolic Dysfunction Associated Steatotic Liver Disease
University of Oxford 10
Not applicableLooking for participantsNCT06203548
What this trial is testing

Monitoring Changes in Hepatic Steatosis Using Continuous Controlled Attenuation Parameter

Who this might be right for
Fatty Liver
Chinese University of Hong Kong 150
Not applicableStudy completedNCT01354626
What this trial is testing

Dietary Protein and Hepatic Fat Accumulation

Who this might be right for
Hepatic Fat AccumulationNonalcoholic Fatty Liver Disease
Wageningen University 29
Testing effectiveness (Phase 2)Study completedNCT05364684
What this trial is testing

The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLDNonalcoholic Fatty LiverNASH - Nonalcoholic Steatohepatitis
Massachusetts General Hospital 12
Next Page